Marc Bonaca, MD
Enriched profileProfessor of Medicine-Cardiology; Executive Director, CPC Clinical Research; Director of Vascular Research; William R. Hiatt Endowed Chair in Cardiovascular Research · University of Colorado Anschutz Medical Campus
Marc Bonaca is Professor of Medicine-Cardiology; Executive Director, CPC Clinical Research; Director of Vascular Research; William R. Hiatt Endowed Chair in Cardiovascular Research at University of Colorado Anschutz Medical Campus. OpenAlex indexes 584 publications with 30,545 citations (h-index 69); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 13 Oct 2026
Marc Bonaca, MD, is Professor of Medicine-Cardiology at University of Colorado Anschutz Medical Campus, School of Medicine, Division of Cardiology. The public record shows 584 publications with 30,545 citations (h-index 69), centered on Peripheral Artery Disease Management, Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 26 companies, 1 NIH-funded awards (2020–2020).
- Top research focus: Peripheral Artery Disease Management
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 26 companies
Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 51 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 215.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19
Sponsor: ARCA Biopharma, Inc.
Industry payments
Updated 13 Oct 2026
26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year202520 payments$89,519openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year202515 payments$33,737openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20258 payments$25,355openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.7%Beta blocker19.3%Carvedilol66%Metoprolol Succinate34%Part D<11 patientsStatin18.9%Atorvastatin Calcium70%Rosuvastatin Calcium30%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
7.4%SGLT2 inhibitor7.4%Jardiance100%Part D≥12 patientsBlood & clotting
4.9%Factor Xa inhibitor4.9%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Oct 2026
1 NIH research award on record, funded 2020–2020 per NIH RePORTER. The latest:
- Proteomics, outcomes and precision treatment of patients with chronic limb threatening ischemia (CLTI).
New York University School of Medicine
FY2026$872,787R01HL183504
Congress activity
Updated 13 Oct 2026
2 congress contributions (2021–2023) across ADA, ENDO per OpenAlex. The most recent:
- THU254 VICTOR-Pilot Study Of A Virtual Dietary Intervention To Improve Diabetes And Cardiovascular Risk In Rural Communities - Primary Results
ENDO Annual Meeting
ENDO2023Co-author - 8-LB: Risk Profile of Comorbid Diabetes and Benefit of Rivaroxaban in Patients with Critical Limb Ischemia: Insights from VOYAGER PAD
ADA Scientific Sessions
ADA2021Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
New England Journal of Medicine
2024 - Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease
New England Journal of Medicine
2023 - Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
European Heart Journal
2022 - Society for Vascular Surgery appropriate use criteria for management of intermittent claudication
Journal of Vascular Surgery
2022
Most-cited works
by citation count (OpenAlex)- 01Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes6,329 citations2018
- 02
- 03Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction1,975 citations2015
- 04
- 05Rivaroxaban in Peripheral Artery Disease after Revascularization988 citations2020
Network
Updated 13 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 13 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/marc-bonaca-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/marc-bonaca-53565b38
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Google Scholar
scholar.google.com/citations
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholar.google.com ↗ - ResearchGate
researchgate.net/profile/Marc-Bonaca-2
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - X / Twitter
x.com/marcbonaca
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- X / Twitter
twitter.com/cpcresearch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →twitter.com ↗ - Other
acc.org/membership/person
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acc.org ↗ - X / Twitter
X/Twitter handle @MarcBonaca (Marc Bonaca MD MPH)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- Internal medicine residency
cardiology fellowship, and vascular medicine fellowship, Brigham and Women's Hospital, Boston, MA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cpcclinicalresearch.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cumedicine.us ↗
Awards & honors
honors on the public record- Inaugural holder
William R. Hiatt Endowed Chair in Cardiovascular Research, University of Colorado School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗
Secondary affiliations
appointments beyond the home institution- Executive Director
CPC Clinical Research (Colorado Prevention Center), Aurora, CO
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗ - Research fellowship / former investigator
TIMI (Thrombolysis in Myocardial Infarction) Study Group, Brigham and Women's Hospital / Harvard Medical School, Boston, MA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗
Media & interviews
press, podcasts and appearances- "VOYAGER, Atherosclerotic Disease, and More: An Interview with Marc Bonaca, MD" - video interview series
Cardio Care Today / DocWire News
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiocaretoday.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiocaretoday.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radcliffeckm.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Satish Garg, MD
University of Colorado Anschutz Medical Campus
Jeffrey Bennett, MD
University of Colorado Anschutz Medical Campus
Jane Reusch, MD
University of Colorado Anschutz Medical Campus
Kevin Deane, MD
University of Colorado Anschutz Medical Campus
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)